FDA In Twilight: Gov’t Shutdown Has Not Slowed Rx Operations Too Visibly Yet
Shutdown puts API shipments on a slow boat, but reviews of existing products can proceed with carry-over funds, even as new applications cannot be filed. CDC has largely halted its influenza program and NIH has ceased enrolling new patients in its clinical center.
You may also be interested in...
US FDA Enters Shutdown Mode: Reviews Will Continue, But Will Morale?
User fee funding will allow many functions to continue, but only 58% of staff will be retained until funding deal is reached.
FDA's Government Shutdown Plan Ready, Just In Case
With a little more than a week left for Congress to extend government funding, US FDA and HHS plan for furloughs should no new appropriations be enacted.
FDA Shutdown Hangover Hurts Biosimilars, May Benefit Some ANDAs
As normal operations – and normal budget worries – resume, the agency has some meetings to reschedule.